Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-04-03
1991-08-27
Rivers, Diana
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
540478, 530391, 530809, 530806, 530828, 424 8591, A61K 31475, A61K 31395, C07D51904, C07K 1528
Patent
active
050433407
ABSTRACT:
Derivatives of 4-desacetyl VLB C-3 carboxhydrazide, active anti-tumor agents and useful as intermediates for active anti-tumor conjugates.
REFERENCES:
patent: 4166810 (1979-09-01), Cullinan et al.
patent: 4191688 (1980-03-01), Conrad et al.
patent: 4203898 (1980-05-01), Cullinan et al.
patent: 4388305 (1983-06-01), Trouet et al.
patent: 4596676 (1986-06-01), Cullinan
patent: 4675400 (1987-06-01), Cullinan
patent: 4801688 (1989-01-01), Laguzza et al.
Ghose et al., CRC Crit. Rev. in Therapeutic Drug Carrier Systems, 3, 263-359 (1987).
Blair and Ghose, J. Immunol. Methods, 59, 129-43 (1983).
Ghose et al., Methods Enzymol. 93, 280-333 (1983).
Eli Lilly and Company
Jones Joseph A.
Rivers Diana
Whitaker Leroy
LandOfFree
Derivatives of 4-desacetyl VLB C-3 carboxhydrazide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of 4-desacetyl VLB C-3 carboxhydrazide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of 4-desacetyl VLB C-3 carboxhydrazide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1414305